Astex Therapeutics Limited

Royaume‑Uni


 
Quantité totale PI 242
Rang # Quantité totale PI 5 393
Note d'activité PI 2,6/5.0    48
Rang # Activité PI 15 406
Parent Astex Pharmaceuticals, Inc.
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

78 9
28 4
112 4
7
 
Dernier brevet 2025 - Isoindolinone inhibitors of the ...
Premier brevet 2002 - Methods of purification of cytoc...
Dernière marque 2015 - A ASTEX PHARMACEUTICALS
Première marque 2000 - AUTOSOLVE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Ether linked triazoles as nrf2 activators. The present invention relates to ether-linked triazol...
Invention Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity. The invention p...
2023 Invention Bicyclic heterocycle compounds and their uses in therapy. The invention relates to bicyclic hete...
Invention Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-...
2022 Invention Pyrrolopyrimidine compounds and their uses. The disclosed compounds relate to treatments and the...
Invention Bicyclic heterocycle compounds and their uses in therapy. The invention relates to new bicyclic h...
Invention Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceuti...
Invention Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceut...
2021 Invention Pyrazolyl quinoxaline kinase inhibitors. The invention relates to new quinoxaline derivative com...
Invention Nrf2 regulators. The present invention relates to aryl analogs, pharmaceutical compositions cont...
Invention Ether linked triazoles as nrf2 activators. The present invention relates to ether-linked triazole...
Invention Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl...
2020 Invention Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n′-(1-methylethyl)-n-[3-(1-methyl-...
Invention A compound having inhibitory activity against kras g12d mutation. The present invention relates t...
Invention 4-aminobut-2-enamide derivatives and salts thereof. The present invention provides an antitumor ...
Invention 4-aminobut-2-enamide derivatives and salts thereof. The present invention provides an antitumor a...
Invention Bicyclic heterocycle compounds and their uses in therapy. The invention relates to bicyclic heter...
Invention Combination of an fgfr inhibitor and a cmet inhibitor. The invention relates to a combination of ...
2019 Invention Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity. The invention pr...
Invention Indanes as nrf2 activators. The present invention relates to indane compounds, methods of making ...
Invention Nrf2 regulators. The present invention relates to aryl analogs, pharmaceutical compositions conta...
2018 Invention Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and mu...
Invention Nrf2 regulators. The present invention relates to bis aryl analogs, pharmaceutical compositions ...
Invention Combinations. The invention relates to a combination of a first compound selected from N-(3,5-dim...
Invention Pharmaceutical compounds. The invention provides a combination comprising: (i) a compound of form...
Invention Combination of isoindolinone derivatives with sgi-110. The invention provides a combination compr...
Invention Isoindolinone inhibitors of the mdm2-p53 interaction and process for making them. The invention r...
2017 Invention Quinoxaline derivatives useful as fgfr kinase modulators. The invention relates to new quinoxalin...
Invention Bisaryl lactams as nrf2 activators. The present invention relates to bisaryl lactam compounds, m...
Invention N-aryl pyrazoles as nrf2 regulators. The present invention relates to N-aryl pyrazole compounds,...
Invention Bisaryl heterocycles as nrf2 activators. The present invention relates to bisaryl heterocycle com...
Invention Bisaryl amides as nrf2 activators. The present invention relates to bisaryl amide analogs, pharma...
2016 Invention Arylcyclohexyl pyrazoles as nrf2 regulators. The present invention relates to arylcyclohexyl pyra...
Invention Biaryl pyrazoles as nrf2 regulators. The present invention relates to biaryl pyrazole compounds o...
Invention Nrf2 regulators. Provided are aryl analogs, pharmaceutical compositions containing them and their...
2015 P/S Pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases a...
2012 P/S Chemicals, chemical compounds and chemical preparations for non-medical purposes, namely, those ...
P/S Chemicals, chemical compounds and chemical preparations and products including those for use in b...
P/S Chemicals, chemical compounds and chemical preparations and products including those for use in ...
P/S Chemicals, chemical compounds and chemical preparations for non-medical purposes, namely, those f...
2011 P/S Providing health care information via the Internet
P/S Computer software for the manipulation and presentation of data for use in relation to drug disco...
P/S Research and development services in the field of pharmaceuticals; providing medical and scientif...
P/S Research and development services in the field of pharmaceuticals; providing medical and scienti...
2005 P/S Chemicals, chemical compounds and products, including those for use in biotechnology, drug discov...
2000 P/S Drug discovery services; biotechnology research [ Computer software for manipulation and presenta...
P/S Computer software for use in relation to drug discovery; computer software for use in relation to...
P/S Pharmaceuticals. Computer software for use in relation to drug discovery; computer software for u...